Correlation Between GeneReach Biotechnology and Taiwan Speciality

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GeneReach Biotechnology and Taiwan Speciality at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneReach Biotechnology and Taiwan Speciality into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GeneReach Biotechnology and Taiwan Speciality Chemicals, you can compare the effects of market volatilities on GeneReach Biotechnology and Taiwan Speciality and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneReach Biotechnology with a short position of Taiwan Speciality. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneReach Biotechnology and Taiwan Speciality.

Diversification Opportunities for GeneReach Biotechnology and Taiwan Speciality

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between GeneReach and Taiwan is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding GeneReach Biotechnology and Taiwan Speciality Chemicals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taiwan Speciality and GeneReach Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneReach Biotechnology are associated (or correlated) with Taiwan Speciality. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taiwan Speciality has no effect on the direction of GeneReach Biotechnology i.e., GeneReach Biotechnology and Taiwan Speciality go up and down completely randomly.

Pair Corralation between GeneReach Biotechnology and Taiwan Speciality

Assuming the 90 days trading horizon GeneReach Biotechnology is expected to under-perform the Taiwan Speciality. But the stock apears to be less risky and, when comparing its historical volatility, GeneReach Biotechnology is 1.74 times less risky than Taiwan Speciality. The stock trades about -0.09 of its potential returns per unit of risk. The Taiwan Speciality Chemicals is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  17,300  in Taiwan Speciality Chemicals on November 7, 2024 and sell it today you would earn a total of  7,150  from holding Taiwan Speciality Chemicals or generate 41.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

GeneReach Biotechnology  vs.  Taiwan Speciality Chemicals

 Performance 
       Timeline  
GeneReach Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GeneReach Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Taiwan Speciality 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Solid
Over the last 90 days Taiwan Speciality Chemicals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly abnormal basic indicators, Taiwan Speciality showed solid returns over the last few months and may actually be approaching a breakup point.

GeneReach Biotechnology and Taiwan Speciality Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GeneReach Biotechnology and Taiwan Speciality

The main advantage of trading using opposite GeneReach Biotechnology and Taiwan Speciality positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneReach Biotechnology position performs unexpectedly, Taiwan Speciality can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taiwan Speciality will offset losses from the drop in Taiwan Speciality's long position.
The idea behind GeneReach Biotechnology and Taiwan Speciality Chemicals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Fundamental Analysis
View fundamental data based on most recent published financial statements
CEOs Directory
Screen CEOs from public companies around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon